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Upregulation of DNA Sensors in B16.F10
Melanoma Spheroid Cells After
Electrotransfer of pDNA
Katarina Znidar, MSc1, Masa Bosnjak, PhD2, Tanja Jesenko, PhD2,
Loree C. Heller, PhD3,4, and Maja Cemazar, PhD1,2
Abstract
Increased expression of cytosolic DNA sensors, a category of pattern recognition receptor, after control plasmid DNA elec-
trotransfer was observed in our previous studies on B16.F10 murine melanoma cells. This expression was correlated with the
upregulation of proinflammatory cytokines and chemokines and was associated with cell death. Here, we expanded our research
to include the influence of features of cells in a 3-dimensional environment, which better represents the tumors’ organization
in vivo. Our results show that lower number of cells were transfected in spheroids compared to 2-dimensional cultures, that
growth was delayed after electroporation alone or after electrotransfer of plasmid DNA, and that DNA sensors DDX60, DAI/
ZBP1, and p204 were upregulated 4 hours and 24 hours after electrotransfer of plasmid DNA. Moreover, the cytokines inter-
feron b and tumor necrosis factor a were also upregulated but only 4 hours after electrotransfer of plasmid DNA. Thus, our
results confirm the results obtained in 2-dimensional cell cultures demonstrating that electrotransfer of plasmid DNA to tumor
cells in spheroids also upregulated cytosolic DNA sensors and cytokines.
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pDNA, plasmid DNA; TNF-a, tumor necrosis factor a.
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Introduction
Gene therapy is gaining its importance in clinical applications
as a replacement of missing or nonfunctional proteins, in the
enhancement of the immune response against cancer, and in
other applications.1-4 There have been approximately 80 clin-
ical studies for the treatment of different diseases utilizing the
gene delivery method electroporation or electrotransfer (http://
ClinicalTrials.gov). Gene electrotransfer is a method by which
cells are exposed to external electric field in order to increase
the permeability of the cell membrane and thus enable the entry
of plasmid DNA (pDNA) into the cell. To better understand the
complexity of gene electrotransfer process, preclinical in vitro
and in vivo studies are performed exploring underlying
mechanisms.5-9
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In preclinical cancer studies using gene electrotransfer,
pDNA devoid of a therapeutic gene serves as a control for
therapeutic pDNA. This DNA causes tumor growth delay,
increased survival time, and complete tumor regression.8,10-
16 A possible explanation for tumor growth delay
and regression is the activation of cytosolic DNA sen-
sors.11,13,14,17 After electrotransfer, pDNA can enter the cells
via endocytosis or hypothetically through pores directly to the
cytosol.18,19 The endosomal DNA is released to the cytosol in
order to reach the cell nucleus. Thus, the result of electro-
transfer is the presence of pDNA inside the cytosol, which
is, in normal cells, DNA free.20 Free DNA in cytosol may bind
to cytosolic DNA sensors, which are a subgroup of pattern
recognition receptors, and consequently activate different
signaling pathways that further lead to the activation of
immune response or cell death.21-23
In a previous study, we demonstrated the upregulation of
specific cytosolic DNA sensors after electrotransfer of pDNA
in melanoma cells in culture.11 This upregulation was accom-
panied with increased expression of cytokine interferon b
(IFN-b). We expanded this research to different tumor cell
types, where we also observed upregulation of some DNA
sensors in mammary adenocarcinoma (TS/A) and fibrosarcoma
(WEHI 164) accompanied with increased expression of IFN-b
and TNF-a.17 We also demonstrated a possible autocrine and/
or paracrine pathway through the interferon a/b receptor 1 and
tumor necrosis factor receptor 1 (TNFR-1) receptors.
Although we obtained confirming results in different tumor
cell lines, here we tested the 3-D conformation of cells for a
better understanding and prediction of the outcome in vivo.
Two-dimensional monolayer cell culture cannot reproduce the
complex organization and architecture of tissue. Consequently,
numerous signals that govern different cellular processes are
lost when cells are grown in 2-dimensional (2-D) plastic sub-
strate. Three-dimensional (3-D) cell cultures also possess sev-
eral in vivo features of tumors such as cell–cell interactions,
hypoxia, limited drug penetration, and the production of extra-
cellular matrix.24 Specifically, for tumor spheroids, the
hypoxic center of the spheroid and lack of nutrients due to
impaired diffusion mimic the in vivo situation. As such they
represent a bridge from 2-D cell cultures to in vivo tumor model
experiments.
For this study, we chose a pulse protocol that has been tested
on B16.F10 cells in suspension, on B16.F10 tumors in vivo,
clinically for the delivery of chemotherapeutic agents and is
currently in gene therapy clinical trials. Delivery of these
pulses kills approximately 10% of B16.F10 cells in suspen-
sion.11,25 No antitumor effects are observed after delivering
these pulses to B16.F10 melanoma tumors.26 This pulse regi-
men has been tested in humans, and no antitumor effect was
observed histologically.27 Eight of these pulses are used clini-
cally for the delivery of chemotherapeutic agents28 and 6 of
these pulses are in clinical trials for plasmid delivery29.
Although similar pulses are used for irreversible electropora-
tion, a significantly higher number of pulses are necessary for
cell or tissue ablation.30
Therefore, the aim of our study was to perform electrotrans-
fer of control pDNA into B16.F10 melanoma spheroids and to
follow spheroid growth, transfection efficiency, expression of
cytosolic DNA sensors and cytokines, and consequent cell
death mechanisms.
Materials and Methods
Cell line and plasmid DNA
Murine melanoma cell line B16.F10 (American Type Culture
Collection, Manassas, Virginia) was cultured in advanced min-
imum essential media (AMEM, Gibco, Thermo Fisher Scien-
tific, Waltham, Massachusetts) supplemented with 5% fetal
bovine serum (FBS; Gibco), 10 mL/L L-glutamine (Gluta-
MAX; Gibco), 100 U/mL penicillin (Grünenthal, Aachen, Ger-
many), and 50 mg/mL gentamicin (Krka, Novo mesto,
SIovenia) in a 5% CO2-humidified incubator at 37
C.
Plasmid DNA encoding enhanced green fluorescent protein,
pEGFP-N1 (pEGFP, BD Biosciences Clontech, Palo Alto,
California), was used for the transfection efficiency experiment
and pVAX (pVAX1, Thermo Fisher Scientific) for all other
experiments, both in concentration of 2 mg/mL. Amplification
of pEGFP was performed in Escherichia coli and purified using
EndoFree Plasmid Mega Kits (Qiagen, Hilden, Germany)
according to the manufacturer’s protocol. The quality and
quantity of isolated plasmid DNA were determined by spectro-
photometric measurements of A260–A280 ratio (Epoch Micro-
plate Spectrophotometer, Take3 Micro-Volume Plate; BioTek,
Winooski, Vermont) and agarose gel electrophoresis (Scie-Plas
ltd, Cambridge, United Kingdom). Plasmid pVAX was manu-
factured by Aldevron (Fargo, North Dakota).
Spheroids Preparation
Melanoma cells were harvested, counted, and 300 cells were
plated in each well of 96-well U-bottom plates (Corning
Incorporated, Corning, New York) in 150 mL of media sup-
plemented with hydroxypropyl methylcellulose in a final con-
centration of 10% (METHOCEL E50 Premium LV
Hypromellose, Dow Chemical Company, Midland, Michi-
gan). Plates were centrifuged for 2 minutes at 1000 rpm.
Then, the spheroids were incubated for 3 days in a 5% CO2-
humidified incubator at 37C, when they reached the size of
approximately 400 mm. At this day, all experiments were
performed, and the day was assigned as day 0. In addition,
control spheroids were embedded in paraffin, cut, and stained
with hematoxylin and eosin (H&E) to visualize the presence
of necrosis in untreated samples.
Electrotransfer Protocol
First, each spheroid was transferred to a sterile 10-cm Petri dish
using a pipette with wide tip opening (Thermo Fisher Scien-
tific) to prevent damage of the spheroid. The media around
spheroid was removed, the spheroid was washed with electro-
poration buffer (125 mmol/L sucrose, 10 mmol/L K2HPO4, 2.5
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mmol/L KH2PO4, 2 mmol/L MgCl2  6H20), and then 45 mL
of electroporation (EP) buffer was added to all the groups. Five
microliter of pDNA in concentration of 2 mg/mL of physiolo-
gical saline (final amount of pDNA to each spheroid was 10 mg)
was added to the plasmid groups (pEGFP or pDNA only
(pDNA), pEGFP þ EP, or pDNA þ EP), whereas in control
(Ctrl) and EP groups, 5 mL of physiological saline was added.
Electrodes with 2-mm gap were placed around the spheroid,
and 6 1300 V/cm pulses of 100-microsecond duration at the
frequency of 4 Hz were applied with an Electro Cell B10 elec-
tric pulse generator (LEROY biotech, L’Union, France).11
After 5 minutes, the spheroids were transferred to 96-well U-
bottom plates in cell medium containing 10% hydroxypropyl
methylcellulose for further analysis (Table 1).
Permeabilization of Spheroids
Spheroid electropermeabilization was measured by propidium
iodide (PI) uptake. Spheroids were prepared for electroporation
as described earlier. Diluted PI (Sigma-Aldrich, St. Louis, Mis-
souri ) was also prepared: 10 mL of 100 mmol/L PI was added to
90 mL of saline.
Two subsets of experiments were then performed. First, 5
mL of PI were added at the time of electroporation and in the
other 2 hours after the electroporation. One minute after the
addition of PI, images were captured at 10 objective magni-
fication with an Olympus IX-70 (Olympus, Hamburg, Ger-
many) and appropriate filters (excitation: 538 nm, emission:
617 nm).
Transfection Efficiency
To determine the transfection efficiency, 24 hours after elec-
trotransfer of pEGFP, spheroids were first imaged by fluores-
cence microscopy by capturing under the visible then
fluorescent light, with a light exposure time of 400 millise-
conds. Images were captured at 10 objective magnification
with an Olympus IX-70 (Olympus) and appropriate filters
(excitation: 460-490 nm, emission: 505 nm).
The same samples were then analyzed by flow cytometry.
For flow cytometry analysis, spheroids were first broken into
single cell suspension by adding 100 mL of trypsin and mild
pipetting. Medium was added, cells were centrifuged, and
resuspended in 300 mL of phosphate-buffered saline (PBS;
Gibco). Cells were analyzed with FACSCanto II flow cyt-
ometer (BD Biosciences, San Jose, California), where a 488-
nm laser (air-cooled, 20 mW solid state) and 530/30-nm
band-pass filter were used for the excitation and detection of
GFP fluorescence, respectively.
Separate samples were prepared for microscopy analysis
with a ZEISS LSM 800 confocal laser scanning microscope
equipped with a W Plan-Apochromat 20 1.0 DIC (UV)
VIS-IR (Carl Zeiss AG, Oberkochen, Germany) objective
using a 519 nm laser, and tiles with z-stack settings were set
to scan the whole spheroid in 3 dimensions to a depth of 80 mm.
Each experiment was repeated 3 times in 2 (Ctrl, EP,
pEGFP) or 5 (pEGFP þ EP) parallels.
Spheroid Growth Observation
At day 0 (the day of the delivery) and every second day up to
day 11, images of the spheroids were captured at 10 objective
magnification with Olympus IX-70 microscope (Olympus).
The area of each spheroid was measured with Fiji software.31
For each experimental group, 12 spheroids were measured, and
average area was calculated. The experiment was repeated
twice. The area of each spheroid was first normalized to day
0 and then for each group, the average was calculated and the
growth curve was plotted.
Determination of Cell Death Mechanism
Cell death mechanisms were determined by FITC Annexin V
Apoptosis Detection Kit with 7-Aminoactinomycin D (7AAD)
(BioLegend, San Diego, California) according to manufactur-
er’s instructions for flow cytometric analysis 24 hours after
electrotransfer of pDNA. To obtain enough cells for the anal-
ysis, 6 spheroids were collected from 1 experimental group.
Table 1. Detailed Scheme of Performed Experiments.
Group Characteristics Transfection Spheroid Growth Cell Death qPCR
Spheroid þ 45 mL of EP buffer
Ctrl 5 mL saline 5 ml saline 5 mL saline 5 mL saline
pDNA 5 mL pEGFP 5 mL pVax 5 mL pVax 5 mL pVax
EP 5 mL saline þ
electroporation
5 mL saline þ
electroporation
5 mL saline þ
electroporation
5 mL saline þ
electroporation
pDNAþ EP 5 mL pEGFP þ
electroporation
5 mL pVax þ
electroporation
5 mL pVax þ
electroporation
5 mL pVax þ
electroporation
No. of spheroids for 1 sample 1 1 1 12
No of parallels in each
experiment
2 (Ctrl, EP, pEGFP)
5 (pEGFP þ EP)
12 6 2
No of experiment replication 3 2 2 2
Treatment type ¼
electroporation
1300 V/cm, 6 pulses, 4 Hz, 100 ms (only in groups with EP)
Abbreviation: qPCR, quantitative polymerase chain reaction.
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The experiment was repeated twice. Spheroids were broken
into single cell suspensions as described earlier. Apoptosis was
evaluated by phosphatidylserine detection in the outer plasma
membrane leaflet using Annexin V and necrosis with 7AAD,
which has a high DNA-binding constant and can pass into the
nucleus and bind to DNA in necrotic cells.
Extraction of RNA From Spheroids and Detection of
DNA Sensors and Cytokines by Quantitative
Polymerase Chain Reaction
Four and 24 hours hours after electrotransfer of pDNA, spher-
oids were collected, and total RNA was extracted by Total
RNA Kit, peqGOLD (VWR, Radnor, Pennsylvania) according
to the manufacturer’s instructions. As many as 12 spheroids
were collected for each experimental group to obtain enough
cells to gain a sufficient amount of RNA for these experiments.
The experiment was repeated twice in 2 parallels.
The concentration and purity of RNA were determined spec-
trophotometrically (Epoch, Biotek, Winooski, Vermont) by
measurements of absorbance at 260 nm and of the ratio of
absorbance at 260 and 280 nm, respectively. Reverse transcrip-
tion of 500 ng of total RNA into complementary DNA (cDNA)
was performed according to the manufacturer’s instructions
(SuperScript VILO cDNA Synthesis Kit, Thermo Fisher Sci-
entific). Quantitative Polymerase Chain Reaction was per-
formed using SYBR Select Master Mix (Thermo Fisher
Scientific) and custom primers for Cyclic GMP-AMP Synthase
(cGAS), DDX60, DAI/ZBP1, p204, IFN-b, and TNF-a (Inte-
grated DNA Technologies, Coralville, Iowa;Table 2) using a
QuantStudio 3 Real-Time PCR System (Thermo Fisher Scien-
tific).11 Relative quantification (DDCt method) was performed
using b-actin and glyceraldehyde 3-phosphate dehydrogenase
as housekeeping genes.32 pDNAþEP samples were normalized
to EP group. Due to the use of 12 spheroids to obtain enough
material, the data are not representing the data of 1 sample but
rather the average of 12 samples.
Statistical Analysis
The data were first tested for normality of distribution with the
Shapiro-Wilk test. The differences between experimental
groups were statistically evaluated by one-way analysis of var-
iance (one-way ANOVA) followed by a Holm-Sidak test for
multiple comparison. A P value of less than 0.05 was consid-
ered as statistically significant difference. For statistical anal-
ysis and graphical representation, SigmaPlot Software (Systat
Software, Chicago, Illinois) was used.
Results
Permeabilization of Spheroids
To determine the effectiveness of permeabilization using this
pulse protocol, we added PI to the spheroids and evaluated the
fluorescence under the microscope (Figure 1). One minute after
electroporation, a scattered fluorescence was visible through-
out the spheroid indicating an effective permeabilization (Fig-
ure 1A). To determine the resealing of the cells’ membrane
after the electroporation, PI was added to the spheroids also 2
hours after the treatment. A blurry fluorescence rim was visi-
ble, indicating that certain percentage of cells died after elec-
troporation alone (Figure 1B).
Transfection Efficiency
Twenty-four hours (day 1) after electrotransfer of pEGFP into
the spheroids, the transfection efficiency was visualized by
fluorescent and confocal microscope and quantitatively deter-
mined by flow cytometry.
Fluorescent images showed that only the rim of each spher-
oid was transfected, while the core was not fluorescent 24 hours
after the transfection (Figure 2A). This observation was con-
firmed by confocal microscopy, where also only the rim of the
spheroid was transfected (Figure 2B). Probably only the part of
the rim at the cathode site was transfected, since during the
electroporation, pDNA is entering at cathode site and travels
toward anode. Flow cytometry analysis showed <2% of trans-
fected cells in the entire spheroid, with a median transfection
efficiency * 2500 a.u (Figure 1C).
Spheroid Growth
Spheroid growth was followed up to 9 days after electrotrans-
fer. After EP only and pDNAþ EP, growth of all spheroids was
delayed until day 4. Thereafter, the growth of the spheroids had
the same rate as the growth of spheroids from control and
plasmid-only group during exponential growth phase. The
spheroids from control and plasmid groups grew exponentially
and reached a plateau at day 4. By days 7 and 9, no groups
differed significantly in size (Figure 3). These results indicate
that after 4 days of delayed growth, spheroid growth recovered




















Abbreviations: GAS, GMP-AMP synthase; DNA-dependent activator of IFN-
regulatory factors; IFN-b, interferon b; qPCR, quantitative polymerase chain
reaction; mRNA, messenger RNA; TNF-a, tumor necrosis factor a.
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completely. These results also indicate that pDNA had no
effect on spheroid growth; the delayed growth was due to the
electric field application, which is in accordance with the PI
data obtained 2 hours after the treatment.
Cell Death Mechanisms
The application of electric pulses to the spheroid can cause cell
death, which may contribute to the growth delay observed in
EP and pDNAþEP conditions. Therefore, a flow cytometry
assay (FITC Annexin V Apoptosis Detection assay with
7AAD) was performed 1 day after the treatment to elucidate
the cell death type (Figure 4). In addition, the H&E staining
was done in control spheroids at the same time point. In con-
trast to monolayer cells, where the control sample contains
approximately 97% viable cells,11 the percentage of viable
cells in spheroids was <10% as determined by flow cytometry.
Hematoxylin and eosin staining of control untreated spheroids
demonstrated the necrotic center and a rim of viable cells (Fig-
ure 4A). Flow cytometry assay showed that approximately 70%
to 80% of each spheroid was composed of necrotic cells (Fig-
ure 4B). After electrotransfer of pDNA, the percentage of
viable (negative) cells decreased and consequently the percent-
age of apoptotic cells increased (Annexin V; P < .05). A similar
pattern was previously observed after electrotransfer of pDNA
of melanoma cells with identical pulses but different pDNA.11
Expression of DNA Sensors and Cytokines
In 2-D cultures, the messenger RNA (mRNAs) and proteins of
select DNA sensors were upregulated after pDNA electrotrans-
fer.11 Messenger RNA expression of different DNA sensors
and cytokines was measured by qPCR. We tested the effect
of pDNA electrotransfer on the mRNA levels of this subset
Figure 1. Permeabilization of spheroids 1 minute (A) and 2 hours after electroporation (EP) (B) with propidium iodide (PI). Bright-field (upper)
and fluorescent (lower) images are shown. Scale Bar ¼ 200 mm.
Figure 2. Transfection efficiency 24 hours after electrotransfer of plasmid DNA (pDNA) to spheroids with Plasmid DNA encoding enhanced
green fluorescent protein (pEGFP) determined by (A) fluorescence and (B) confocal microscope and (C) by flow cytometry. Red Dots (Panel A
and B) indicate approximate borders of the spheroid. *Statistically significant difference compared to all other groups (P < .05).
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of sensors along with a sensor for which the mRNA levels did
not change, cGas, in 3-D cultures. Four hours after electrotrans-
fer of pDNA to spheroids, statistically significantly increased
levels of mRNA were detected for DAI/ZBP1 (40-fold) and
DDX60 (25-fold) but not for p204 (8-fold; Figure 5). At 24
hours, the mRNA levels for those 2 sensors were reduced but
still significantly upregulated compared to the EP group. On
the other hand, the mRNA levels for p204 (20-fold) became
significantly increased after 24 hours. No increase in cGAS
mRNA levels was detected. At 4 hours, the mRNA expression
significantly increased 100-fold for IFN-b and 20-fold for
TNF-a compared to the EP group, while at 24 hours, the
increase was no longer significant.
Discussion
In this study, we demonstrated that electrotransfer of pDNA of
tumor cells in spheroids caused increased expression of
cytosolic DNA sensors and cytokines. This confirmed our
results obtained in 2-D cell cultures.11,33
Our previous in vitro and in vivo research on B16.F10 tumor
cells and murine tumor models demonstrated that after electro-
transfer of pDNA, there is a pronounced effect on the growth of
tumor cells and on experimental tumors. In vitro, these effects
correlated with changes in the expression of a subset of DNA
sensors.11 The same observations were made in the present
study on a spheroid model of B16.F10 cells where these same
DNA sensors were upregulated. The peak upregulation was
detected 4 hours after electrotransfer of pDNA and decreased
over time. The upregulation of DDX60 and p204 DNA sensors
was very similar to the upregulation obtained in 2-D cell cul-
ture; however, the upregulation of DAI/ZBP1 was significantly
lower (P < .05).
The levels of IFN-b levels were significantly higher (P <
.05) to that obtained in 2-D cell cultures but much higher than
the levels obtained in tumors.11 Interestingly, in melanoma
tumors in vivo, DNA sensor mRNAs were not upregulated,
Figure 3. Spheroid growth after electrotransfer of pDNA. *Statistically significant difference compared to Ctrl and pDNA groups (P < .05).
Figure 4. Histological image of B16.F10 spheroid stained with hematoxylin and eosin (H&E). Red arrow indicate necrotic center and blue
arrows indicate cells in mitosis (A). Percentage of viable cells (negative), apoptotic (annexin V), Late apoptotic/necrotic (Annexin Vþ 7 AAD)
and necrotic (7 AAD) cells after electrotransfer of pDNA of B16.F10 Spheroids. *P < .05 compared to control group (B).
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whereas IFN-b levels were significantly increased on mRNA
and protein level.11 This indicates that the presence of other
cells in tumors, particularly immune cells, may complicate the
detection of DNA sensor upregulation while contributing to the
production of cytokines. Since upregulation is not synonymous
with activation, it is also possible that alternative sensors
may be initially activated and responsible for the production
of INF-b. The specific upregulated sensors may act later in the
pathway.
The transfection efficiency of electrotransfer using a
plasmid-encoding GFP was very low and comparable to that
obtained in vivo. The transfection pattern was very similar as in
in vivo models; mainly the rim was transfected while the core
remained intact.34 Thus from this point of view, spheroids
represent a good model for tumors in vivo. Furthermore, the
very low transfection efficiencies confirmed results obtained in
other studies using different cell types or spheroids composed
of 2 cell types.35,36
Although the control spheroids contain a very high percent-
age of necrotic cells, the increase in percentage of apoptotic
cells in spheroids after electrotransfer was detectable. The elec-
trotransfer of pDNA caused similar pattern of cell death as was
previously observed in 2-D cell cultures.11 Specifically, an
increased proportion of apoptotic cells was detected without
additional necrotic cells. Despite the significant loss of cell
viability in pDNAþEP group compared to other groups, the
growth rate of the spheroids treated with EP alone and com-
bined with pDNA was identical. This growth was delayed until
day 4 and then accelerated to achieve the same size as control
spheroids by day 7. This effect of EP alone was previously
observed in other studies and was ascribed to the loss of via-
bility of the cells in outer layers.37,38 The loss of cell viability
was ascribed to the cell size, the size of necrotic core, and other
cell properties within the spheroids, such as cell-to-cell junc-
tions and extracellular matrix secretion.37,38 However, such
viability loss is not in accordance with the results obtained
either in 2-D cell cultures or in tumors, where the addition of
pDNA to EP significantly reduced cell viability. In tumors, an
additional difference in cell survival could be explained by the
activation of immune system. However, the difference between
2-D cultures and spheroids is difficult to explain and deserves
further studies.14
In conclusion, our results on spheroids confirm the results
obtained in 2-D cell cultures demonstrating that electrotransfer
of pDNA to tumor cells in spheroids upregulated cytosolic
DNA sensors and cytokines. In addition, the growth of spher-
oids was delayed after electric field application.
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